Pulse Biosciences's total assets for Q2 2026 were $115.56M, an increase of 41.58% from the previous quarter. DE:6L8 total liabilities were $16.06M for the fiscal quarter, a 4.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.